Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 3/20 | 0.31 |
| ▸ | TERT | O14746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4673267 | 0.89 | HTT (0.35) | HTTSMN1; SMN2CNR1TERT | |
| SCHEMBL4671088 | 0.89 | HTT (0.35) | HTTSMN1; SMN2CNR1TERT | |
| SCHEMBL6321380 | 0.89 | HTT (0.35) | HTTSMN1; SMN2CNR1TERT | |
| SCHEMBL4673163 | 0.89 | HTT (0.35) | HTTSMN1; SMN2CNR1TERT | |
| SCHEMBL4674836 | 0.89 | HTT (0.35) | HTTSMN1; SMN2CNR1TERT | |
| SCHEMBL4671491 | 0.88 | CNR1 (0.35) | HTTSMN1; SMN2CNR1 | |
| SCHEMBL4670960 | 0.85 | PRKDC (0.39) | HTTSMN1; SMN2 | |
| SCHEMBL4676232 | 0.85 | PRKDC (0.39) | HTTSMN1; SMN2 | |
| SCHEMBL4677173 | 0.85 | PRKDC (0.39) | HTTSMN1; SMN2 | |
| SCHEMBL4673869 | 0.85 | PRKDC (0.39) | HTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1461330-B1 | 3H-NAPHTHO[2,1-b]-PYRANE DERIVATIVES AND THEIR USE | RODENSTOCK GMBH (DE) | 2008-03-12 | — | — | EP | claimed |
| US-6967249-B2 | Photochromic 3H-naphtho[2,1-b]-pyran compounds and photochromic articles produced therewith | RODENSTOCK GMBH (DE) | 2005-11-22 | — | — | US | claimed |
| US-20040267013-A1 | Photochromic 3H-naphtho[2,1-b]-pyran compounds and photochromic articles produced therewith | RODENSTOCK GMBH | 2004-12-30 | — | — | US | claimed |
| EP-1461330-B1 | 3H-NAPHTHO[2,1-b]-PYRANE DERIVATIVES AND THEIR USE | RODENSTOCK GMBH (DE) | 2008-03-12 | — | — | EP | disclosed |
| US-6967249-B2 | Photochromic 3H-naphtho[2,1-b]-pyran compounds and photochromic articles produced therewith | RODENSTOCK GMBH (DE) | 2005-11-22 | — | — | US | disclosed |
| US-20040267013-A1 | Photochromic 3H-naphtho[2,1-b]-pyran compounds and photochromic articles produced therewith | RODENSTOCK GMBH | 2004-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040267013-A1 | Photochromic 3H-naphtho[2,1-b]-pyran compounds and photochromic articles produced therewith | RB1, TERB1, CRY2 | HTT 473/4885SMN1; SMN2 4501/4885CNR1 3883/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.